Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
IPATH S&P 500 VIX SHORT-TERM FUTURES ETN DUE 1/30/2019

VXX-OLD2

IPATH S&P 500 VIX SHORT-TERM FUTURES ETN DUE 1/30/2019

IPATH S&P 500 VIX SHORT-TERM FUTURES ETN DUE 1/30/2019 historical holders

total: 2

Lone Pine Capital IPATH S&P 500 VIX SHORT-TERM FUTURES ETN DUE 1/30/2019 transactions over time

Total transactions:
5
New positions:
1
Sold out:
1
Added:
2
Reduced:
1
Held since:
2016 Q4
Held for:
5 quarters
Latest activity:
2018 Q1
Stephen Mandel has been an institutional investor in IPATH S&P 500 VIX SHORT-TERM FUTURES ETN DUE 1/30/2019 (VXX-OLD2) since 2016 Q4. According to 2026 Q1 report, Stephen Mandel doesn't hold any shares. The fund/company first acquired VXX-OLD2 in 2016 Q4, initially purchasing 500,000 shares. Since the initial investment, Lone Pine Capital has made 4 more transactions in this position.

When did Stephen Mandel exit their VXX-OLD2 position?

Stephen Mandel no longer holds IPATH S&P 500 VIX SHORT-TERM FUTURES ETN DUE 1/30/2019 (VXX-OLD2). They sold off their entire position in 2018 Q1, closing out an investment that began in 2016 Q4.

When did Stephen Mandel first invest in VXX-OLD2?

Stephen Mandel first invested in IPATH S&P 500 VIX SHORT-TERM FUTURES ETN DUE 1/30/2019 (VXX-OLD2) in 2016 Q4 at the reported quarter-end price of $25.51 per share, acquiring 500,000 shares in their initial purchase.

What is Stephen Mandel's average cost basis for VXX-OLD2?

Based on historical transaction data, Stephen Mandel's estimated cost basis for IPATH S&P 500 VIX SHORT-TERM FUTURES ETN DUE 1/30/2019 (VXX-OLD2) is approximately $20.04 per share. This represents their average reported price* across all buy transactions.

Estimated cost basis*

Weighted AVG buy price:
$20.04
Weighted AVG sell price:
$36.37

VXX-OLD2 transactions history by Lone Pine Capital

5 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2018 Q1
0.00%
$27.92
-100% (-250,000)
2017 Q3
0.05%
$39.19
-75.00% (-750,000)
2017 Q2
0.06%
$12.76
+25.00% (+200,000)
2017 Q1
0.07%
$15.79
+60.00% (+300,000)
2016 Q4
0.07%
$25.51
new
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.